CareLit · DOI-Nachweis · Pneumologie
The influence of EGF/HGF signaling crosstalk on therapy resistance in NSCLC cell lines
DOI 10.1055/s-0034-1376829
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Salopiata, H Hass, D Rauh, RM Huber, J Timmer, U Klingmüller
ZeitschriftPneumologie
Ausgabe06/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Therapeutic treatment of NSCLC includes mainly chemotherapy due to high metastatic spread but recently also targeted therapy using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) for patients with an EGFR-activating mutation. Although patients benefit from this treatment, the NSCLC cancer develops a r…
Zitieren
Zitierempfehlung
F Salopiata, H Hass, D Rauh, RM Huber, J Timmer, U Klingmüller (2014) The influence of EGF/HGF signaling crosstalk on therapy resistance in NSCLC cell lines. Pneumologie (06). https://doi.org/10.1055/s-0034-1376829
Mit CareLit weiterarbeiten